3,354 Shares in Colgate-Palmolive Company $CL Purchased by Samalin Investment Counsel LLC

Key Points

• Samalin Investment Counsel LLC acquired 3,354 shares of Colgate-Palmolive Company, valued at approximately $314,000, during the first quarter of the year.
• Colgate-Palmolive reported $0.92 earnings per share (EPS) for the latest quarter, surpassing expectations, with a quarterly revenue of $5.11 billion.
• The company recently announced a quarterly dividend of $0.52 per share, reflecting an annualized yield of 2.5% and a payout ratio of 58.43%.

Samalin Investment Counsel LLC acquired a new position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,354 shares of the company's stock, valued at approximately $314,000.

Several other large investors have also recently added to or reduced their stakes in CL. Westend Capital Management LLC lifted its stake in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 140 shares during the last quarter. Cornerstone Planning Group LLC lifted its stake in Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after buying an additional 287 shares during the last quarter. Vermillion Wealth Management Inc. bought a new stake in Colgate-Palmolive in the fourth quarter valued at $31,000. Accredited Wealth Management LLC bought a new stake in Colgate-Palmolive in the fourth quarter valued at $34,000. Finally, Bernard Wealth Management Corp. bought a new stake in Colgate-Palmolive in the fourth quarter valued at $36,000. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent research reports. Morgan Stanley cut their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Citigroup cut their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Wall Street Zen cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Finally, UBS Group cut their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $98.92.

Colgate-Palmolive Price Performance

Shares of CL stock traded up $0.62 during midday trading on Monday, reaching $84.04. 3,934,689 shares of the company were exchanged, compared to its average volume of 4,656,227. Colgate-Palmolive Company has a 12 month low of $82.40 and a 12 month high of $109.30. The company has a market cap of $67.92 billion, a P/E ratio of 23.61, a PEG ratio of 4.37 and a beta of 0.35. The company's 50 day moving average price is $87.15 and its two-hundred day moving average price is $89.86. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive's revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 EPS. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Friday, July 18th. Colgate-Palmolive's payout ratio is presently 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.